Microbiome Center, Department of Surgery, University of Chicago, Chicago, Illinois, USA.
Bioscience Division, Argonne National Laboratory, Lemont, Illinois, USA.
Nat Med. 2018 Apr 10;24(4):392-400. doi: 10.1038/nm.4517.
Our understanding of the link between the human microbiome and disease, including obesity, inflammatory bowel disease, arthritis and autism, is rapidly expanding. Improvements in the throughput and accuracy of DNA sequencing of the genomes of microbial communities that are associated with human samples, complemented by analysis of transcriptomes, proteomes, metabolomes and immunomes and by mechanistic experiments in model systems, have vastly improved our ability to understand the structure and function of the microbiome in both diseased and healthy states. However, many challenges remain. In this review, we focus on studies in humans to describe these challenges and propose strategies that leverage existing knowledge to move rapidly from correlation to causation and ultimately to translation into therapies.
我们对人类微生物组与疾病(包括肥胖、炎症性肠病、关节炎和自闭症)之间关系的理解正在迅速扩展。通过对与人类样本相关的微生物群落的基因组进行 DNA 测序的通量和准确性的改进,辅以对转录组、蛋白质组、代谢组和免疫组的分析,以及在模型系统中进行的机制实验,极大地提高了我们理解微生物组在疾病和健康状态下的结构和功能的能力。然而,仍有许多挑战。在这篇综述中,我们专注于在人类中进行的研究,描述这些挑战,并提出利用现有知识从相关性快速推进到因果关系,并最终转化为治疗方法的策略。